Sort
21,281 grants matching “influenza”
Glycoengineering In Vivo
$2,610,000Robert McCullough Anthony · Massachusetts General Hospital · DP2 · FY2014 · AR
Aging and Immunity to Infections
$2,607,586Laura Haynes · Trudeau Institute, Inc. · P01 · FY2010 · AG
Influenza Immunity: Protective Mechanisms Against Pandemic Respiratory Virus
$2,606,671Mark M Davis · Stanford University · U19 · FY2013 · AI
CEIRR Data Processing and Communications Center Activities for Universal Influenza Vaccine Research
$2,605,020Stephan Bour · Digital Infuzion, Inc. · N01 · FY2023 · AI
Cell Signaling of Host Defense
$2,604,382Michael B Fessler · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
NIAID Influenza Data Processing and Communication Center: Universal Influenza Vaccine Research Activities
$2,600,000Stephan Bour · Digital Infuzion, Inc. · N01 · FY2025 · AI
Resources and Workforce Development for Research on NIH/NIAID High Priority Pathogens at the University of Missouri Regional Biocontainment Laboratory
$2,595,464Wendy L Picking · University Of Missouri-Columbia · UC7 · FY2023 · AI
Human immune memory to COVID-19, vaccines, and respiratory pathogens
$2,595,434Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2024 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$2,595,163Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2018 · AI
US-UK Collab: Integrating metaviromics with epidemiological dynamics: understanding virus transmission in the Anthropocene
$2,593,622Barbara A Han · Cary Institute Of Ecosystem Studies, Inc. · · FY2023 · BIO
ADVANCE VACCINE PLATFORMS FOR UNIVERSAL INFLUENZA VACCINE
$2,591,547Patti Labbe · Leidos Biomedical Research, Inc. · N01 · FY2019 · CA
Computational Models of Infectious Disease Threats
$2,589,058Donald S. Burke · University Of Pittsburgh At Pittsburgh · U54 · FY2011 · GM
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE
$2,579,515Kathleen Neuzil · University Of Maryland Baltimore · N01 · FY2019 · AI
University of Washington Vaccine and Treatment Evaluation Unit
$2,579,381Anna Wald · University Of Washington · UM1 · FY2024 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$2,579,232David S Stephens · Emory University · UM1 · FY2023 · AI
Membrane Remodeling in Viral Infection, Parasite Replication, and Traumatic Brain Injury
$2,579,164Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Components And Kinetics In Exocytosis
$2,579,164Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) â Gritstone, Variant, & Pediatric Vaccine Trials
$2,577,219David S Stephens · Emory University · UM1 · FY2021 · AI
Human immune memory to COVID-19, vaccines, and respiratory pathogens
$2,576,765Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2025 · AI
Virus-induced Cell Fate Decisions in Anti-Viral Immunity
$2,571,328Troy D Randall · University Of Alabama At Birmingham · U19 · FY2017 · AI
Tomotherapy and Hematopoietic Stem Cells For Tolerance to Kidney Transplants
$2,570,030Dixon B Kaufman · University Of Wisconsin-Madison · U01 · FY2013 · AI
Design Of Immunogens
$2,567,806Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Computing Infrastructure to Advance Biomedical Research
$2,566,410Thomas Furlani · State University Of New York At Buffalo · S10 · FY2010 · RR
Clinical Studies of Vaccines for Pandemic Influenza
$2,564,575Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Therapeutic Monoclonal Antibodies to H5N1 Influenza
$2,562,311Richard John Webby · St. Jude Children'S Research Hospital · U01 · FY2009 · AI